SCHEMBL10137342

SCHEMBL10137342

CC1(C)OB(c2cncc(N3CCOCC3)n2)OC1(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.37
ALDH1A1 P00352 5/20 0.37
HPGD P15428 3/20 0.37
MEN1 O00255 2/20 0.37
KDM4E B2RXH2 2/20 0.37
GAA P10253 2/20 0.37
MAPT P10636 2/20 0.37
HTT P42858 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
LMNA P02545 1/20 0.37
RECQL P46063 1/20 0.37
HSD17B10 Q99714 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
CRHBP P24387 1/20 0.36
CRHR2 Q13324 1/20 0.36
POLB P06746 1/20 0.35
CYP11B1 P15538 1/20 0.34
CYP11B2 P19099 1/20 0.34
PIM2 Q9P1W9 1/20 0.34
CYP1A2 P05177 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31015657 0.88 PDE10A (0.34) KMT2AALDH1A1HPGDMEN1KDM4E
SCHEMBL10137347 0.86 HRH4 (0.39) ALDH1A1KDM4EHSD17B10CYP11B1CYP11B2
SCHEMBL10169024 0.82 KMT2A (0.33) KMT2AALDH1A1HPGDMEN1KDM4E
SCHEMBL9989079 0.80 GAA (0.43) KMT2AALDH1A1HPGDMEN1KDM4E
SCHEMBL12731668 0.78 ALDH1A1 (0.40) KMT2AALDH1A1HPGDMEN1KDM4E
SCHEMBL31372447 0.78 ALDH1A1 (0.40) KMT2AALDH1A1HPGDMEN1KDM4E
SCHEMBL896991 0.76 KMT2A (0.56) KMT2AALDH1A1MEN1KDM4EGAA
SCHEMBL1136870 0.74 POLB (0.46) KMT2AALDH1A1HPGDMEN1KDM4E
SCHEMBL12614839 0.72 ALDH1A1 (0.38) KMT2AALDH1A1HPGDMEN1KDM4E
SCHEMBL9885000 0.72 KMT2A (0.53) KMT2AALDH1A1HPGDMEN1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120208792-A1 PROTEIN KINASE MODULATORS CYLENE PHARMACEUTICALS, INC. (US) 2012-08-16 US disclosed
US-20120208792-A1 PROTEIN KINASE MODULATORS CYLENE PHARMACEUTICALS, INC. (US) 2012-08-16 US disclosed
US-8168651-B2 Protein kinase modulators CYLENE PHARMACEUTICALS, INC. (US) 2012-05-01 US disclosed
US-20090239859-A1 PROTEIN KINASE MODULATORS SENHWA BIOSCIENCES, INC. (TW) 2009-09-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120208792-A1 PROTEIN KINASE MODULATORS PIM1, PIM2, PIM3 KMT2A 1381/4885ALDH1A1 3801/4885HPGD 3408/4885
US-20090239859-A1 PROTEIN KINASE MODULATORS PIM1, PIM2, PIM3 KMT2A 1381/4885ALDH1A1 3801/4885HPGD 3408/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.